Topotecan Terminated Phase 1 Trials for Renal Cell Adenocarcinoma / Rectal Carcinoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00158886Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer